The NAM Working Group has successfully launched and is actively growing into a cross‑industry, cross‑sector network connecting industry, academia, and regulators. Following a strong kickoff presentation and clearly defined scope, the group now includes representatives from multiple pharmaceutical companies as well as FDA participants.
To support focused scientific collaboration, we have established dedicated subgroups in:
- Immunogenicity / Immunotoxicity
- DMPK
The NAM Working Group is also emerging as a visible thought‑leadership forum by:
If you're interested in contributing to scientific discussion, regulatory engagement, and the advancement of NAMs across disciplines, we welcome new members to join and shape the next phase of this growing community.
Vibha Jawa and Pooja Khanna
------------------------------
Pooja Khanna
Senior Scientist
Merck & Co, Inc - Rahway, NJ
Lower Gwynedd Township PA
[email protected]Disclaimer: Opinions expressed are solely my own and do not express the views or opinions of my employer.
------------------------------